These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36196423)

  • 1. The use of the normal tissue non-complication probability (NTCP0) methodology as a new alternative of assessing side-effects in brachytherapy treatments.
    Frometa-Castillo T; Pyakuryal A; Narayanasamy G; Mesbahi A; Wals-Zurita A
    Rep Pract Oncol Radiother; 2022; 27(4):602-609. PubMed ID: 36196423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of the normal tissue non-complication probability (NTCP0) in the safety evaluations as a new alternative of assessing the side-effects of the radiation oncology treatments.
    Frometa-Castillo T; Pyakuryal A; Narayanasamy G; Wals-Zurita A; Mesbahi A
    Int J Radiat Biol; 2023; 99(4):656-662. PubMed ID: 35930494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposals of models for new formulations of the current complication-free cure (P+) and uncomplicated tumor control probability (UTCP) concepts, and total normal tissue complication probability of late complications.
    Frometa-Castillo T; Pyakuryal A; Wals-Zurita A; Mesbahi A
    Int J Radiat Biol; 2020 Jul; 96(7):847-850. PubMed ID: 32163306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling normal tissue complication probability from repetitive computed tomography scans during fractionated high-dose-rate brachytherapy and external beam radiotherapy of the uterine cervix.
    Dale E; Hellebust TP; Skjønsberg A; Høgberg T; Olsen DR
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):963-71. PubMed ID: 10863066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ipsilateral lung normal tissue complication probability parameters for different dose calculation algorithms in radiotherapy of breast cancer.
    Kavousi N; Nedaie HA; Gholami S; Esfahani M; Shafiekhani S; Hassani M
    J Cancer Res Ther; 2020; 16(6):1323-1330. PubMed ID: 33342791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of normal tissue complications following prostate cancer irradiation: comparison of radiation treatment modalities using NTCP models.
    Takam R; Bezak E; Yeoh EE; Marcu L
    Med Phys; 2010 Sep; 37(9):5126-37. PubMed ID: 20964232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of different dose calculation algorithms on the estimate of NTCP for lung complications.
    Hedin E; Bäck A
    J Appl Clin Med Phys; 2013 Sep; 14(5):127-39. PubMed ID: 24036865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of late rectal normal tissue complication probability parameters in carbon ion therapy for prostate cancer.
    Fukahori M; Matsufuji N; Himukai T; Kanematsu N; Mizuno H; Fukumura A; Tsuji H; Kamada T
    Radiother Oncol; 2016 Jan; 118(1):136-40. PubMed ID: 26700600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal tissue complication probability modeling to guide individual treatment planning in pediatric cranial proton and photon radiotherapy.
    Dell'Oro M; Wilson P; Short M; Hua CH; Merchant TE; Bezak E
    Med Phys; 2022 Jan; 49(1):742-755. PubMed ID: 34796509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of radiation-induced liver disease using the Lyman NTCP model.
    Dawson LA; Normolle D; Balter JM; McGinn CJ; Lawrence TS; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):810-21. PubMed ID: 12095546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A stochastic model for the normal tissue complication probability (NTCP) and applicationss.
    Stocks T; Hillen T; Gong J; Burger M
    Math Med Biol; 2017 Dec; 34(4):469-492. PubMed ID: 27591250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal Tissue Complication Probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: A Test of the QUANTEC-recommended NTCP model.
    Liu M; Moiseenko V; Agranovich A; Karvat A; Kwan W; Saleh ZH; Apte AA; Deasy JO
    Acta Oncol; 2010 Oct; 49(7):1040-4. PubMed ID: 20831493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal tissue complication probability (NTCP) models of acute urinary toxicity (AUT) following carbon ion radiotherapy (CIRT) for prostate cancer.
    Li Y; Li P; Hsi W; Hong Z; Fu S; Zhang Q
    Radiother Oncol; 2021 Mar; 156():69-79. PubMed ID: 33309999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
    Rancati T; Fiorino C; Gagliardi G; Cattaneo GM; Sanguineti G; Borca VC; Cozzarini C; Fellin G; Foppiano F; Girelli G; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
    Radiother Oncol; 2004 Oct; 73(1):21-32. PubMed ID: 15465142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can reduction of uncertainties in cervix cancer brachytherapy potentially improve clinical outcome?
    Nesvacil N; Tanderup K; Lindegaard JC; Pötter R; Kirisits C
    Radiother Oncol; 2016 Sep; 120(3):390-396. PubMed ID: 27452410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the uncertainty in a normal tissue complication probability difference (∆NTCP): radiation-induced liver disease (RILD) in liver tumour patients treated with proton vs X-ray therapy.
    Kobashi K; Prayongrat A; Kimoto T; Toramatsu C; Dekura Y; Katoh N; Shimizu S; Ito YM; Shirato H
    J Radiat Res; 2018 Mar; 59(suppl_1):i50-i57. PubMed ID: 29538699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability.
    Seppenwoolde Y; Lebesque JV; de Jaeger K; Belderbos JS; Boersma LJ; Schilstra C; Henning GT; Hayman JA; Martel MK; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):724-35. PubMed ID: 12573760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of dose calculation algorithms on the predicted dose distribution and NTCP values for NSCLC patients.
    Nielsen TB; Wieslander E; Fogliata A; Nielsen M; Hansen O; Brink C
    Med Phys; 2011 May; 38(5):2412-8. PubMed ID: 21776775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the NTCP modeling on medical decision to select eligible patient for proton therapy: the usefulness of EUD as an indicator to rank modern photon vs proton treatment plans.
    Chaikh A; Calugaru V; Bondiau PY; Thariat J; Balosso J
    Int J Radiat Biol; 2018 Sep; 94(9):789-797. PubMed ID: 29878849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models.
    Rancati T; Wennberg B; Lind P; Svane G; Gagliardi G
    Radiother Oncol; 2007 Mar; 82(3):308-16. PubMed ID: 17224197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.